biostudies-literatureUnknown21Rungmaitree S<b>Background:</b> Adolescents and young adults with HIV (AYHIV) are at high-risk of loss to follow up and virologic failure, particularly during transition from pediatric to adult clinics. <b>Methods:</b> We reviewed the medical records of AYHIV to characterize retention and virologic suppression following their transition. <b>Results:</b> 101 AYHIV, 97% perinatally infected, were transferred at the median age of 20 (IQR: 19-21) years. At 1-year post-transition, 92.1% were retained in care and 73.3% had viral suppression and at 2-years the retention and viral suppression were 87.1% and 76.7%, respectively. Factors associated with viral suppression were transition at ≥ 20 years of age (aOR 4.38, 95% CI 1.41-13.65) and receiving first-line ART regimen, compared to second- or third-line regiJournal of the International Association of Providers of AIDS Care23259582221143673https://www.ebi.ac.uk/biostudies/studies/S-EPMC9732801biostudies-literatureThe Outcomes of Transition from Pediatrics to Adult Care among Adolescents and Young Adults with HIV at a Tertiary Care Center in Bangkok.PMC9732801Wittawatmongkol OPhongsamart WSachdev SLapphra KHoffman RMKhumcha BMaleesatharn AThamniamdee NChokephaibulkit KRungmaitree SfalseThe Outcomes of Transition from Pediatrics to Adult Care among Adolescents and Young Adults with HIV at a Tertiary Care Center in Bangkok.<b>Background:</b> Adolescents and young adults with HIV (AYHIV) are at high-risk of loss to follow up and virologic failure, particularly during transition from pediatric to adult clinics. <b>Methods:</b> We reviewed the medical records of AYHIV to characterize retention and virologic suppression following their transition. <b>Results:</b> 101 AYHIV, 97% perinatally infected, were transferred at the median age of 20 (IQR: 19-21) years. At 1-year post-transition, 92.1% were retained in care and 73.3% had viral suppression and at 2-years the retention and viral suppression were 87.1% and 76.7%, respectively. Factors associated with viral suppression were transition at ≥ 20 years of age (aOR 4.38, 95% CI 1.41-13.65) and receiving first-line ART regimen, compared to second- or third-line regi2022-01-01T00:00:00Z2022 Jan-Dec2025-04-05T12:52:49.097Z2025-04-05T12:52:49.097ZS-EPMC97328013647445710.1177/23259582221143673